Genenta Science S.p.A. American Depositary Shares
Symbol: GNTA (NASDAQ)
2.93
▲ (6.36%) 0.175
Company Description:
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Key Stats
- Today's Open: $2.86
- Today's High: $3.049
- Today's Low: $2.735
- Today's Volume: 23.55K
- Yesterday Close: $2.75
- Yesterday High: $3.5
- Yesterday Low: $2.56
- Yesterday Volume: 164.18K
- Last Min Volume: 40
- Last Min High: $2.925
- Last Min Low: $2.925
- Last Min VWAP: $2.925
Company Profile
- Name: Genenta Science S.p.A. American Depositary Shares
- Website: https://www.genenta.com
- Listed Date: 2021-12-15
- Location: ,
- Market Status: Active
- CIK Number: 0001838716
- SIC Code:
- SIC description:
- Market Cap: $62.73M
- Round Lot: 100
- Outstanding Shares: 18.29M
- Asset Type: ADRC
RECENT FILINGS FOR GNTA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 6-K | View |
| 2025-08-01 | 6-K | View |
| 2025-03-28 | 424B5 | View |
| 2025-03-28 | 20-F | View |
| 2025-03-19 | 6-K | View |
| 2025-03-19 | 6-K | View |
| 2025-02-10 | SCHEDULE 13G/A | View |
| 2024-12-30 | 6-K | View |
| 2024-12-20 | 6-K | View |
| 2024-12-20 | 424B5 | View |
| 2024-12-13 | 6-K | View |
| 2024-11-14 | 6-K | View |
| 2024-10-29 | 6-K | View |
| 2024-05-03 | 6-K | View |
| 2024-04-26 | 6-K | View |
| 2024-04-26 | 424B5 | View |
| 2024-04-08 | 6-K | View |
| 2024-04-02 | 6-K | View |
| 2024-04-01 | 20-F/A | View |
| 2024-03-29 | S-8 | View |
Latest News on GNTA